Trade Medical Properties Reit - MPW CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Medical Properties Trust Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Key Stats
| Prev. Close* | 4.93 |
| Open* | 4.97 |
| 1-Year Change* | -56.78% |
| Day's Range* | 4.93 - 5.23 |
| 52 wk Range | 6.38-15.16 |
| Average Volume (10 days) | 8.56M |
| Average Volume (3 months) | 242.89M |
| Market Cap | 4.03B |
| P/E Ratio | 57.69 |
| Shares Outstanding | 598.40M |
| Revenue | 1.42B |
| EPS | 0.12 |
| Dividend (Yield %) | 8.9153 |
| Beta | 1.06 |
| Next Earnings Date | Oct 25, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Oct 4, 2023 | 5.23 | 0.29 | 5.87% | 4.94 | 5.26 | 4.91 |
| Oct 3, 2023 | 4.93 | -0.20 | -3.90% | 5.13 | 5.17 | 4.90 |
| Oct 2, 2023 | 5.20 | -0.19 | -3.53% | 5.39 | 5.43 | 5.14 |
| Sep 29, 2023 | 5.43 | 0.22 | 4.22% | 5.21 | 5.50 | 5.21 |
| Sep 28, 2023 | 5.21 | 0.19 | 3.78% | 5.02 | 5.25 | 5.02 |
| Sep 27, 2023 | 5.01 | -0.02 | -0.40% | 5.03 | 5.12 | 4.95 |
| Sep 26, 2023 | 5.01 | -0.15 | -2.91% | 5.16 | 5.21 | 4.97 |
| Sep 25, 2023 | 5.26 | 0.03 | 0.57% | 5.23 | 5.33 | 5.11 |
| Sep 22, 2023 | 5.32 | -0.02 | -0.37% | 5.34 | 5.41 | 5.18 |
| Sep 21, 2023 | 5.28 | -0.35 | -6.22% | 5.63 | 5.67 | 5.28 |
| Sep 20, 2023 | 5.77 | -0.28 | -4.63% | 6.05 | 6.07 | 5.76 |
| Sep 19, 2023 | 6.00 | -0.04 | -0.66% | 6.04 | 6.13 | 5.97 |
| Sep 18, 2023 | 6.08 | -0.16 | -2.56% | 6.24 | 6.29 | 6.07 |
| Sep 15, 2023 | 6.35 | -0.12 | -1.85% | 6.47 | 6.47 | 6.22 |
| Sep 14, 2023 | 6.55 | 0.08 | 1.24% | 6.47 | 6.61 | 6.45 |
| Sep 13, 2023 | 6.40 | 0.07 | 1.11% | 6.33 | 6.46 | 6.29 |
| Sep 12, 2023 | 6.55 | 0.13 | 2.02% | 6.42 | 6.59 | 6.36 |
| Sep 11, 2023 | 6.47 | -0.18 | -2.71% | 6.65 | 6.67 | 6.45 |
| Sep 8, 2023 | 6.61 | -0.10 | -1.49% | 6.71 | 6.72 | 6.55 |
| Sep 7, 2023 | 6.70 | -0.23 | -3.32% | 6.93 | 6.94 | 6.70 |
Medical Properties Reit Events
| Time (UTC) | Country | Event |
|---|---|---|
| Wednesday, October 25, 2023 | ||
| Time (UTC) 12:30 | Country US
| Event Q3 2023 Medical Properties Trust Inc Earnings Release Q3 2023 Medical Properties Trust Inc Earnings ReleaseForecast -Previous - |
| Wednesday, February 21, 2024 | ||
| Time (UTC) 13:30 | Country US
| Event Q4 2023 Medical Properties Trust Inc Earnings Release Q4 2023 Medical Properties Trust Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 1542.85 | 1544.67 | 1249.24 | 854.197 | 784.522 |
| Revenue | 1542.85 | 1544.67 | 1249.24 | 854.197 | 784.522 |
| Cost of Revenue, Total | 39.997 | 32.798 | 18.89 | 18.192 | 9.237 |
| Gross Profit | 1502.85 | 1511.87 | 1230.35 | 836.005 | 775.285 |
| Total Operating Expense | 807.543 | 505.985 | 439.804 | 293.747 | 271.33 |
| Selling/General/Admin. Expenses, Total | 166.194 | 151.938 | 137.663 | 102.211 | 80.086 |
| Depreciation / Amortization | 332.977 | 321.249 | 264.245 | 152.313 | 133.083 |
| Unusual Expense (Income) | 268.375 | 0 | 19.006 | 21.031 | 48.924 |
| Operating Income | 735.308 | 1038.68 | 809.434 | 560.45 | 513.192 |
| Interest Income (Expense), Net Non-Operating | -327.688 | -366.555 | -336.491 | -227.885 | -223.274 |
| Gain (Loss) on Sale of Assets | 536.755 | 52.471 | -2.833 | 41.56 | 719.392 |
| Other, Net | 15.344 | 6.288 | -6.782 | -0.345 | 10.094 |
| Net Income Before Taxes | 959.719 | 730.888 | 463.328 | 373.78 | 1019.4 |
| Net Income After Taxes | 903.819 | 656.94 | 432.272 | 376.401 | 1018.48 |
| Minority Interest | -1.222 | -0.919 | -0.822 | -1.717 | -1.792 |
| Net Income Before Extra. Items | 902.597 | 656.021 | 431.45 | 374.684 | 1016.68 |
| Net Income | 902.597 | 656.021 | 431.45 | 374.684 | 1016.68 |
| Total Adjustments to Net Income | -1.602 | -2.161 | -2.105 | -2.308 | -3.685 |
| Income Available to Common Excl. Extra. Items | 900.995 | 653.86 | 429.345 | 372.376 | 1013 |
| Income Available to Common Incl. Extra. Items | 900.995 | 653.86 | 429.345 | 372.376 | 1013 |
| Diluted Net Income | 900.995 | 653.86 | 429.345 | 372.376 | 1013 |
| Diluted Weighted Average Shares | 598.837 | 590.139 | 530.461 | 428.299 | 366.271 |
| Diluted EPS Excluding Extraordinary Items | 1.50457 | 1.10798 | 0.80938 | 0.86943 | 2.76571 |
| Dividends per Share - Common Stock Primary Issue | 1.16 | 1.12 | 1.08 | 1.02 | 1 |
| Diluted Normalized EPS | 1.08251 | 1.02806 | 0.84779 | 0.83827 | 0.93685 |
| Total Extraordinary Items | |||||
| Dilution Adjustment | 0 |
| Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|
| Total revenue | 337.395 | 350.211 | 380.486 | 352.339 | 400.226 |
| Revenue | 337.395 | 350.211 | 380.486 | 352.339 | 400.226 |
| Cost of Revenue, Total | 24.676 | 7.11 | 7.699 | 8.265 | 21.135 |
| Gross Profit | 312.719 | 343.101 | 372.787 | 344.074 | 379.091 |
| Total Operating Expense | 424.683 | 222.232 | 400.421 | 127.457 | 144.327 |
| Selling/General/Admin. Expenses, Total | 35.604 | 41.724 | 42.893 | 37.319 | 38.858 |
| Depreciation / Amortization | 364.403 | 83.86 | 81.454 | 81.873 | 84.334 |
| Unusual Expense (Income) | 0 | 89.538 | 268.375 | ||
| Operating Income | -87.288 | 127.979 | -19.935 | 224.882 | 255.899 |
| Interest Income (Expense), Net Non-Operating | -93.062 | -86.302 | -84.853 | -76.61 | -73.564 |
| Gain (Loss) on Sale of Assets | 0.167 | 0.062 | -0.033 | 68.795 | 16.355 |
| Other, Net | -10.512 | -5.166 | -20.106 | 23.532 | 2.031 |
| Net Income Before Taxes | -190.695 | 36.573 | -124.927 | 240.599 | 200.721 |
| Net Income After Taxes | -42.433 | 33.03 | -140.212 | 222.02 | 190.064 |
| Minority Interest | 0.396 | -0.236 | -0.262 | -0.227 | -0.467 |
| Net Income Before Extra. Items | -42.037 | 32.794 | -140.474 | 221.793 | 189.597 |
| Net Income | -42.037 | 32.794 | -140.474 | 221.793 | 189.597 |
| Total Adjustments to Net Income | -0.469 | -0.515 | -0.567 | -0.288 | -0.345 |
| Income Available to Common Excl. Extra. Items | -42.506 | 32.279 | -141.041 | 221.505 | 189.252 |
| Income Available to Common Incl. Extra. Items | -42.506 | 32.279 | -141.041 | 221.505 | 189.252 |
| Diluted Net Income | -42.506 | 32.279 | -141.041 | 221.505 | 189.252 |
| Diluted Weighted Average Shares | 598.344 | 598.31 | 598.052 | 599.339 | 599.026 |
| Diluted EPS Excluding Extraordinary Items | -0.07104 | 0.05395 | -0.23583 | 0.36958 | 0.31593 |
| Dividends per Share - Common Stock Primary Issue | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 |
| Diluted Normalized EPS | -0.07122 | 0.18901 | 0.05589 | 0.26366 | 0.29008 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Cash and Short Term Investments | 235.668 | 459.227 | 549.884 | 1462.29 | 820.868 |
| Cash & Equivalents | 235.668 | 459.227 | 549.884 | 1462.29 | 820.868 |
| Total Receivables, Net | 787.166 | 728.522 | 490.462 | 334.231 | 220.848 |
| Total Assets | 19658 | 20519.8 | 16829 | 14467.3 | 8843.64 |
| Property/Plant/Equipment, Total - Net | 17693.5 | 16440.1 | 13512.6 | 10877.9 | 6700.85 |
| Property/Plant/Equipment, Total - Gross | 15917.8 | 17425.8 | 14337.9 | 11438.1 | 7165.83 |
| Accumulated Depreciation, Total | -1193.31 | -993.1 | -833.529 | -570.042 | -464.984 |
| Note Receivable - Long Term | 394.874 | 1384.88 | 904.576 | 576.189 | 399.053 |
| Other Assets, Total | 546.765 | 326.021 | 247.835 | 289.733 | 702.024 |
| Payable/Accrued | 621.324 | 607.792 | 438.75 | 291.489 | 204.325 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 42.6 | 70.851 | 52.831 | 29.626 | 27.524 |
| Total Liabilities | 11065.2 | 12079.6 | 9490.48 | 7439.28 | 4296.54 |
| Total Long Term Debt | 10270.3 | 11284.7 | 8867.39 | 7025.61 | 4037.39 |
| Long Term Debt | 10268.4 | 11282.8 | 8865.46 | 7023.68 | 4037.39 |
| Minority Interest | 1.569 | 5.483 | 5.325 | 0.107 | 13.83 |
| Other Liabilities, Total | 27.727 | 25.563 | 36.177 | 16.098 | 13.467 |
| Total Equity | 8592.84 | 8440.19 | 7338.53 | 7028.05 | 4547.11 |
| Common Stock | 0.597 | 0.597 | 0.541 | 0.518 | 0.371 |
| Additional Paid-In Capital | 8535.14 | 8564.79 | 7461.5 | 7008.2 | 4442.95 |
| Retained Earnings (Accumulated Deficit) | 116.285 | -87.691 | -71.411 | 83.012 | 162.768 |
| Treasury Stock - Common | -0.777 | -0.777 | -0.777 | -0.777 | |
| Other Equity, Total | -59.184 | -36.727 | -51.324 | -62.905 | -58.202 |
| Total Liabilities & Shareholders’ Equity | 19658 | 20519.8 | 16829 | 14467.3 | 8843.64 |
| Total Common Shares Outstanding | 597.476 | 596.814 | 541.419 | 517.522 | 370.637 |
| Total Inventory | 0 | ||||
| Long Term Investments | 1181.03 | 1123.62 | 926.99 | ||
| Accrued Expenses | 101.592 | 85.217 | 90.006 | 76.353 | |
| Capital Lease Obligations | 1.938 | 1.937 | 1.935 | 1.932 | |
| Preferred Stock - Non Redeemable, Net | 0 | 0 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Cash and Short Term Investments | 302.321 | 235.668 | 299.171 | 257.269 | 248.846 |
| Cash & Equivalents | 302.321 | 235.668 | 299.171 | 257.269 | 248.846 |
| Total Receivables, Net | 810.911 | 787.166 | 710.082 | 702.683 | 660.421 |
| Total Assets | 19650.2 | 19658 | 19043.4 | 19743.1 | 19817.8 |
| Property/Plant/Equipment, Total - Net | 17512.2 | 17667.3 | 17115 | 17878.9 | 18252.6 |
| Property/Plant/Equipment, Total - Gross | 15903 | 15917.8 | 15353.8 | 16088.2 | 16316.6 |
| Accumulated Depreciation, Total | -1207.7 | -1193.31 | -1088.91 | -1109.59 | -1054.36 |
| Long Term Investments | |||||
| Note Receivable - Long Term | 445.878 | 394.874 | 317.8 | 308.103 | 132.896 |
| Other Assets, Total | 578.853 | 572.99 | 601.387 | 596.163 | 523.109 |
| Payable/Accrued | 595.269 | 621.324 | 569.017 | 562.255 | 595.026 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 144.092 | 146.13 | 146.438 | 154.974 | 166.626 |
| Total Liabilities | 11208.5 | 11065.2 | 10211.6 | 10883.3 | 10904.4 |
| Total Long Term Debt | 10438.2 | 10268.4 | 9476.14 | 10138.8 | 10118 |
| Long Term Debt | 10438.2 | 10268.4 | 9476.14 | 10138.8 | 10118 |
| Minority Interest | 1.574 | 1.569 | 1.466 | 6.038 | 5.906 |
| Other Liabilities, Total | 29.391 | 27.727 | 18.569 | 21.21 | 18.834 |
| Total Equity | 8441.68 | 8592.84 | 8831.78 | 8859.83 | 8913.45 |
| Common Stock | 0.598 | 0.597 | 0.599 | 0.599 | 0.599 |
| Additional Paid-In Capital | 8541.41 | 8535.14 | 8537.14 | 8557.12 | 8547.89 |
| Retained Earnings (Accumulated Deficit) | -25.413 | 116.285 | 433.339 | 385.545 | 369.972 |
| Treasury Stock - Common | |||||
| Other Equity, Total | -74.919 | -59.184 | -139.301 | -83.431 | -5.01 |
| Total Liabilities & Shareholders’ Equity | 19650.2 | 19658 | 19043.4 | 19743.1 | 19817.8 |
| Total Common Shares Outstanding | 598.302 | 597.476 | 598.983 | 598.839 | 598.676 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 903.819 | 656.94 | 432.272 | 376.401 | 1018.48 |
| Cash From Operating Activities | 739.01 | 811.656 | 617.636 | 494.117 | 449.088 |
| Cash From Operating Activities | 345.577 | 333.781 | 275.953 | 156.575 | 141.492 |
| Deferred Taxes | 0.043 | -12.697 | 19.819 | 5.581 | 0.145 |
| Non-Cash Items | -423.556 | -192.184 | -107.81 | -91.984 | -733.877 |
| Cash Interest Paid | 353.838 | 326.406 | 309.92 | 211.163 | 221.779 |
| Changes in Working Capital | -86.873 | 25.816 | -2.598 | 47.544 | 22.851 |
| Cash From Investing Activities | 396.056 | -3858.41 | -2946.77 | -4883.96 | 564.178 |
| Capital Expenditures | -1442.2 | -5417.96 | -4317.53 | -4649.39 | -1484.96 |
| Other Investing Cash Flow Items, Total | 1838.26 | 1559.55 | 1370.76 | -234.565 | 2049.14 |
| Cash From Financing Activities | -1342.52 | 2947.61 | 1401.07 | 5041.88 | -345.87 |
| Financing Cash Flow Items | -88.554 | -36.674 | -20.641 | -62.317 | -24.22 |
| Total Cash Dividends Paid | -698.535 | -643.473 | -567.969 | -411.697 | -363.906 |
| Issuance (Retirement) of Stock, Net | -17.94 | 1051.23 | 411.101 | 2533.21 | 94.239 |
| Issuance (Retirement) of Debt, Net | -537.494 | 2576.53 | 1578.58 | 2982.69 | -51.983 |
| Foreign Exchange Effects | -12.887 | 4.662 | 16.441 | -6.478 | -17.218 |
| Net Change in Cash | -220.344 | -94.487 | -911.622 | 645.566 | 650.178 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 33.03 | 903.819 | 1044.03 | 822.011 | 631.947 |
| Cash From Operating Activities | 135.648 | 739.01 | 557.915 | 344.016 | 179.387 |
| Cash From Operating Activities | 87.586 | 345.577 | 260.717 | 176.077 | 88.76 |
| Deferred Taxes | 0.6 | 0.043 | -8.185 | -5.347 | -7.646 |
| Non-Cash Items | 33.135 | -423.556 | -670.198 | -582.6 | -499.554 |
| Cash Interest Paid | 116.436 | 353.838 | 285.417 | 209.445 | 111.012 |
| Changes in Working Capital | -18.703 | -86.873 | -68.45 | -66.125 | -34.12 |
| Cash From Investing Activities | 17.178 | 396.056 | 858.311 | 534.128 | 879.034 |
| Capital Expenditures | -86.192 | -1442.2 | -1070.03 | -1037.41 | -760.91 |
| Other Investing Cash Flow Items, Total | 103.37 | 1838.26 | 1928.34 | 1571.54 | 1639.94 |
| Cash From Financing Activities | -89.125 | -1342.52 | -1543.69 | -1062.72 | -1263.82 |
| Financing Cash Flow Items | -8.464 | -88.554 | -85.492 | -43.542 | -19.117 |
| Total Cash Dividends Paid | -176.58 | -698.535 | -524.536 | -350.519 | -176.494 |
| Issuance (Retirement) of Stock, Net | -17.94 | 0 | 0 | 0 | |
| Issuance (Retirement) of Debt, Net | 95.919 | -537.494 | -933.661 | -668.661 | -1068.2 |
| Foreign Exchange Effects | 2.927 | -12.887 | -29.739 | -14.786 | -4.721 |
| Net Change in Cash | 66.628 | -220.344 | -157.202 | -199.364 | -210.116 |
| Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 14.4063 | 86207127 | -1697057 | 2023-06-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 9.5423 | 57100848 | -1725856 | 2023-06-30 | LOW |
| Cohen & Steers Capital Management, Inc. | Investment Advisor/Hedge Fund | 7.7073 | 46120255 | 45452713 | 2023-06-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 5.5966 | 33489816 | -2931107 | 2023-06-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.9546 | 11696619 | 217430 | 2023-06-30 | LOW |
| CenterSquare Investment Management LLC. | Investment Advisor | 1.8477 | 11056716 | 4047 | 2023-06-30 | LOW |
| Daiwa Asset Management Co., Ltd. | Investment Advisor | 1.6281 | 9742667 | 9516400 | 2023-06-30 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.4382 | 8606200 | 67165 | 2023-06-30 | LOW |
| Balyasny Asset Management LP | Hedge Fund | 1.1838 | 7083748 | 2841987 | 2023-06-30 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 1.1063 | 6620368 | 125140 | 2023-06-30 | LOW |
| Cardinal Capital Management, L.L.C. | Investment Advisor | 1.031 | 6169509 | -501861 | 2023-06-30 | LOW |
| Sarasin & Partners LLP | Investment Advisor | 1.0205 | 6106507 | -507489 | 2022-12-31 | MED |
| Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.8087 | 4839035 | -1014418 | 2023-06-30 | LOW |
| Morgan Stanley & Co. LLC | Research Firm | 0.7557 | 4522167 | -34636 | 2023-06-30 | MED |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7309 | 4373960 | -88757 | 2023-06-30 | LOW |
| LSV Asset Management | Investment Advisor | 0.7289 | 4361814 | -6400 | 2023-06-30 | LOW |
| AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 0.6017 | 3600840 | -273107 | 2023-06-30 | LOW |
| Nuveen LLC | Pension Fund | 0.6003 | 3591995 | 385400 | 2023-06-30 | LOW |
| Sumitomo Mitsui Trust Bank, Limited | Bank and Trust | 0.5893 | 3526081 | -1161922 | 2023-06-30 | LOW |
| PGGM Vermogensbeheer B.V. | Pension Fund | 0.5784 | 3461281 | 126745 | 2023-01-31 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Medical Properties Company profile
Founded in 2003, Medical Properties Trust, Inc. bridges the gap between the growing demand for high-quality healthcare and the ability to deliver it cost-effectively. Specialising in acute-care, community and rehabilitation hospitals, this healthcare real estate investment trust (REIT) provides operators access to capital for facility improvements, technology upgrades, staff additions and new construction through long-term net leases of real estate assets. By reinvesting non-earning assets into operations, MPT clients are able to participate in the growth of the largest sector of the U.S. economy. The company’s facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities. The company’s properties are located in various states of the United States, the United Kingdom, Italy, Germany and Spain. To learn the latest Medical Properties share price, follow Capital.com.| Industry: | Healthcare REITs |
1000 Urban Center Drive, Suite 501
BIRMINGHAM
ALABAMA 35242
US
Income Statement
- Annual
- Quarterly
News
How to Trade The Triple Top
Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.
14:13, 27 September 2023
Q4 lookahead: US indices starting to show signs of trouble?
US indices start to draw attention as traders focus on the outlook for Q4.
07:20, 27 September 2023
USD/JPY Climbs Towards Key Highs
USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.
11:32, 26 September 2023
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com